1-3 of 3
bleomycin/dacarbazine/doxorubicin/vinblastine protocol
Close
Sort by
Journal Articles

Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approach

Clinical Trials & Observations
Phoebe T. M. Cheng, Diego Villa, R. Petter Tonseth, David W. Scott, Alina S. Gerrie, Ciara L. Freeman, Tom Pickles, Andrea C. Lo, Pedro Farinha, Jeffrey W. Craig, Graham W. Slack, Randy D. Gascoyne, François Bénard, Don Wilson, Brian Skinnider, Joseph M. Connors, Laurie H. Sehn, Kerry J. Savage
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3647–3655.
https://doi.org/10.1182/bloodadvances.2021004375
Published: 2021
Journal Articles

Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma

Clinical Trials & Observations
Victor M. Orellana-Noia, Krista Isaac, Mary-Kate Malecek, Nancy L. Bartlett, Timothy J. Voorhees, Natalie S. Grover, Steven R. Hwang, N. Nora Bennani, Rachel Hu, Brian T. Hill, Eric Mou, Ranjana H. Advani, Jordan Carter, Kevin A. David, Hatcher J. Ballard, Jakub Svoboda, Michael C. Churnetski, Gabriela Magarelli, Tatyana A. Feldman, Jonathon B. Cohen, Andrew M. Evens, Craig A. Portell
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3623–3632.
https://doi.org/10.1182/bloodadvances.2021004645
Published: 2021
Includes: Supplemental data
Journal Articles

ABVD followed by BV consolidation in risk-stratified patients with limited-stage Hodgkin lymphoma

Clinical Trials & Observations
Steven I. Park, Thomas C. Shea, Oludamilola Olajide, Nishitha M. Reddy, Lihua E. Budde, Nilanjan Ghosh, Allison M. Deal, Jeanne F. Noe, Stephen M. Ansell
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2548–2555.
https://doi.org/10.1182/bloodadvances.2020001871
Published: 2020
Includes: Supplemental data